Repare Therapeutics Inc. Real Estate Contracts & Agreements
12 Contracts & Agreements
- Lease Agreements (12 contracts)
- First Amendment to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REIT II Corp. PPP, dated August 26, 2024 (Filed With SEC on November 7, 2024)
- Commencement Date Memorandum to the Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREF America REIT II Corp. PPP, dated February 25, 2022 (Filed With SEC on March 1, 2022)
- Fifth Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and The Manufacturers Life Insurance Company, dated January 17, 2022 (Filed With SEC on March 1, 2022)
- Lease Agreement by and between the registrant, Repare Therapeutics Inc. and RREEF America REITH II Corp. PPP , dated July 31, 2021 (Filed With SEC on August 12, 2021)
- Fourth Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and The Manfacturers Life Insurance Company, dated June 22, 2021 (Filed With SEC on August 12, 2021)
- Third Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021 (Filed With SEC on August 12, 2021)
- Addendum to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021 (Filed With SEC on August 12, 2021)
- Second Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 11, 2020 (Filed With SEC on November 12, 2020)
- Lease Agreement by and between the registrant and NEOMED Institute, dated November 26, 2019, as amended June 5, 2020 (Filed With SEC on June 15, 2020)
- Lease Agreement by and between the registrant and NEOMED Institute, dated November 26, 2019 (Filed With SEC on May 29, 2020)
- Lease Assignment Agreement by and between the registrant and Pharmascience Inc., dated June 7, 2017 (Filed With SEC on May 29, 2020)
- Lease by and between CIG III Technoparc Nominee Inc. and Pharmascience Inc., dated May 15, 2014, as amended November 24, 2016 and November 25, 2019 (Filed With SEC on May 29, 2020)